Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00464061 · ClinicalTrials.gov registry record · Phase 3
Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus
A Phase 3 study, sponsored by Sanofi.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1,847
- Enrollment target
NCT00464061: Clinical Trial Phase 3 study, sponsored by Sanofi.
NCT00464061 is a Phase 3 study that was terminated before completion, run by Sanofi. The registered enrollment target is 1,847 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (139% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00464061, a Phase 3 study, was terminated before completion, sponsored by Sanofi.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1,847 participants
- Enrollment target
Study Summary
The purpose of this study is to assess efficacy and safety of volinanserin in the population of patients complaining of sleep maintenance insomnia. The objective of the substudy is to assess glycemic control in the subgroup of patients with type II diabetes mellitus.
Interventions
- DRUG Placebo
- DRUG Volinanserin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,847 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-03 |
| Phase | Phase 3 |
Why NCT00464061 stopped before completion
NCT00464061 is an interventional study that assigns participants to a tested intervention. Its 1,847 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (139% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00464061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00464061 about?
NCT00464061 is a clinical study titled "Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus". The purpose of this study is to assess efficacy and safety of volinanserin in the population of patients complaining of sleep maintenance insomnia. The objective of the substudy is to assess glycemic control in the subgroup of patients with type II diabetes mellitus.
What is the current status of trial NCT00464061?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1,847 participants. The study started on 2007-04. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00464061?
The interventions under investigation include: Placebo (DRUG), Volinanserin (DRUG).
Who is sponsoring clinical trial NCT00464061?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00464061's enrollment target sits among peer trials
1,847 114th of 2000 higher than 1,887 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia